Nature Medicine Articles Support GenoMed's Pending Patent on Bird Flu
Contact: David W. Moskowitz MD CEO, GenoMed tel. 314.983.9933 dwmoskowitz@genomed.com
ST. LOUIS—October 10, 2006—GenoMed™ (OTC Pink Sheets GMED), the Next Generation Disease Management company whose business is public health™, announced today that its approach to avian influenza ("bird flu") is now supported by the prestigious journal Nature Medicine.
Click here for Nature Medicine article of September 10, 2006 nature.com
Click here for Nature Medicine article of September 8, 2006 nature.com
Said Dr. David Moskowitz, GenoMed's CEO and Chief Medical Officer, "It has taken the virology community a long time to recognize the lethality of high cytokine levels. We realized it four years ago. Two years ago, we published that our anti-inflammatory approach works for another lethal viral disease, West Nile virus encephalitis."
Dr. Moskowitz continued, "Unfortunately, the current Nature Medicine articles still point to the danger of a high viral load and call for anti-viral drugs. We believe that cytokines kill the patient, not the virus. GenoMed's approach is to convert patients to asymptomatic viral shedders, which is what happens naturally whenever a patient recovers from any viral illness. Our approach should make antiviral drugs unnecessary for the general population. For this reason GenoMed's general viral antidote was included in BioShield II (Section 2151)"
Added Dr. Moskowitz, "At this point, as with the rest of our treatments (Daily Newstown article), the crucial element missing is public awareness. We're reminded every day that if people had only known about us earlier, we could have saved their lives."
About GenoMed
GenoMed owns "use" patents (which are pending) for the use of already existing, safe blood pressure pills to treat many diseases besides high blood pressure, including avian influenza. GenoMed estimates that it can already save 25% of healthcare costs and extend life by 5 years. The company is trying to get the world to realize this sooner rather than later.
. |
